- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Behavioral Inhibition
Total 66112 results
-
Nanjing Medical UniversityCompletedImmune Checkpoint Inhibitor | Endocrine ToxicityChina
-
M.D. Anderson Cancer CenterRigel Pharmaceuticals,Inc.Not yet recruitingMutant IDH1 Inhibitor OlutasidenibUnited States
-
Groupe Hospitalier Paris Saint JosephCompletedProton Pump InhibitorFrance
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSafety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer (RADIOCOM)Chemotherapeutic Toxicity | Radiotherapy; Complications | PARP Inhibitor | Immune Checkpoint Inhibitor | Trastuzumab | Breast Cancer, Familial Male | CDK4/6 Inhibitor | PertuzumabChina
-
University of LincolnCompletedParent-Child Relations | Child Behavior ProblemUnited Kingdom
-
Sun Yat-sen UniversityRecruitingSolid Tumor | Intestinal Flora | Immune Checkpoint InhibitorChina
-
Funch-Jensen, Peter, M.D., D.M.Sc.Medtronic - MITGCompletedPain | Obesity | Surgery | Neuromuscular InhibitionDenmark
-
Northwestern UniversityCompletedCancer | Communication | Medication Adherence | Cancer, Treatment-Related | Tyrosine Kinase InhibitorUnited States
-
American Thrombosis and Hemostasis NetworkTakeda; CSL Behring; OctapharmaCompletedHemophilia A | Hemophilia B | Hemophilia | Hemophilia A With Inhibitor | Haemophilia | Hemophilia B With Inhibitor | Haemophilia A Without Inhibitor | Haemophilia B Without InhibitorUnited States
-
University of Kansas Medical CenterRecruitingHMG-CoA Reductase Inhibitor ToxicityUnited States
-
Mario Negri Institute for Pharmacological ResearchFederico II University; IRCCS MultimedicaCompletedProton Pump Inhibitor | Primary CareItaly
-
Radboud University Medical CenterCompletedProton Pump Inhibitor | Inappropriate Drug Use | Discontinuation | E-healthNetherlands
-
Assiut UniversityUnknownProton Pump Inhibitor Allergy
-
Assiut UniversityUnknownProton Pump Inhibitor Allergy
-
Institut Mutualiste MontsourisInstitut CurieRecruitingCancer | Immune Checkpoint Inhibitor | Cardiovascular BiomarkersFrance
-
AccareRecruitingBehavioral Symptoms | Behavior Problems | Behavioral Problems | Disruptive Behavior | Problem Behaviors | Behavioral DifficultiesNetherlands
-
Institut Mutualiste MontsourisRecruitingCancer | Cardiovascular Complication | Immune Checkpoint Inhibitor | Immune-related Adverse EventFrance
-
Bursa Postgraduate HospitalCompletedContrast Agents and Oral Factor Xa InhibitorTurkey
-
University of KentuckyDonJoy OrthopedicsCompletedPost-operative Quadriceps Weakness | Post-operative Quadriceps Inhibition | Adherence to Post-operative Treatment | Post-operative Lower Extremity FunctionUnited States
-
American Thrombosis and Hemostasis NetworkGenentech, Inc.Active, not recruitingHemophilia A With Inhibitor | Hemophilia B With Inhibitor | Haemophilia A Without Inhibitor | Haemophilia B Without InhibitorUnited States
-
Catalyst BiosciencesCompletedHemophilia A | Hemophilia B | Hemophilia A With Inhibitor | Hemophilia B With Inhibitor | Hemophilia A Without Inhibitor | Hemophilia B Without InhibitorBulgaria, Russian Federation
-
Novartis PharmaceuticalsCompletedPre-menopausal Breast Cancer | PI3K Pathway InhibitionTaiwan, Hong Kong, Thailand, Korea, Republic of
-
Cancer Institute and Hospital, Chinese Academy...Peking University; Peking University Cancer Hospital & InstituteRecruitingMalignant Tumor | Positron Emission Tomography | Fibroblast Activation Protein InhibitorChina
-
Hellenic Cooperative Oncology GroupCompletedAutoimmune Diseases | Immunotherapy | Checkpoint InhibitorGreece
-
Ronald BuckanovichGenentech, Inc.RecruitingPARP Inhibitor | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Hedgehog InhibitorUnited States
-
Fondation Ophtalmologique Adolphe de RothschildCompletedMEK Inhibitor-Associated Serous RetinopathyFrance
-
Samsung Medical CenterSuspendedAromatase (CYP19) Polymorphism Between AI-responsive and AI-resistant Breast Cancer in Korea (CYP19)Polymorphism | CYP19 | Aromatase InhibitorKorea, Republic of
-
Zhongnan HospitalRecruitingMalignant Neoplasm | PET/CT | Fibroblast Activation Protein InhibitorChina
-
Rijnstate HospitalTerminatedCOPD Exacerbation | Enoximone | Phosphodiesterase InhibitorNetherlands
-
Northumbria UniversityPlant & food Research LtdCompletedPharmacodynamic Profile of 'Blackadder' Blackcurrant Juice Effects Upon the Monoamine Axis in HumansMonoamine Oxidase Inhibitor Activity | Prolactin Levels | Postprandial Blood Glucose
-
Atsushi KawakamiGilead SciencesRecruitingRheumatoid Arthritis | Biomarker | JAK Inhibitor | Musculoskeletal Ultrasound | IL-6 InhibitorJapan
-
Schülke & Mayr GmbHCompletedInhibition of Plaque Formation (by Gingivitis-Index ≤1.5)Germany
-
Schülke & Mayr GmbHCompletedInhibition of Plaque Formation (by Gingivitis-Index ≤1.5)Austria, Germany
-
TakedaCompletedErectile Dysfunction | Phosphodiesterase 5 InhibitorMexico
-
Radboud University Medical CenterCompletedCardiovascular Diseases | Muscle Damage | HMG COA Reductase Inhibitor Adverse ReactionNetherlands
-
Amsterdam UMC, location VUmcRecruitingBehavior ProblemNetherlands
-
Penn State UniversityCompletedPediatric Obesity | Inhibition | Decision Making | fMRIUnited States
-
University GhentResearch Foundation FlandersRecruitingAnterior Cruciate Ligament Reconstruction | ACL Injury | Athrogenic Muscle Responses | Arthrogenic Muscle InhibitionBelgium
-
Medical University of GrazCompletedPatients on Long-term Proton Pump Inhibitor TherapyAustria
-
Istituto Clinico HumanitasRecruitingKnee Osteoarthritis | Arthrogenic Muscle InhibitionsItaly
-
Dr Abdurrahman Yurtaslan Ankara Oncology Training...CompletedProton Pump Inhibitor Adverse ReactionTurkey
-
AstraZenecaCompletedFGFR Inhibition, Pharmacokinetics, Biomarkers | ER+ Breast CancerCzech Republic, Italy, United Kingdom, Hungary, Germany, Romania, Belgium, France
-
Sun Yat-sen UniversityRecruitingPD-1 Inhibitor | G-CSFChina
-
Vigonvita Life SciencesCompletedErectile Dysfunction | Alcohol | Phosphodiesterase InhibitorChina
-
Pharvaris Netherlands B.V.RecruitingHereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditionsUnited States, Puerto Rico
-
Vanderbilt UniversityVanderbilt University Medical CenterCompletedBehavioral ProblemUnited States
-
Spectrum Pharmaceuticals, IncCompletedEGFR Inhibitor-associated RashUnited States, Canada
-
American University of Beirut Medical CenterTakedaCompletedGERD | Proton Pump InhibitorLebanon
-
AccareRecruitingBrief Parent Training for Children With Behavioral Difficulties in Primary Care Settings (PAINT-POH)Behavioral DifficultiesNetherlands
-
Shanghai Tong Ren HospitalRecruitingEarly PCSK9 Inhibitor on Ventricular RemodlingChina